While Moderna’s Vaccine Offers Hope, Absence of Data Raises Doubt
A COVID-19 vaccine—created by Moderna in collaboration with the National Institute of Allergy and Infectious Diseases (NIAID)—seems to initiate an immune response in a Phase 1 trial, giving hope to the possibility of an effective vaccine in…